This document is a USPTO patent application (US20260083762A1) related to the use of sialic acid compositions to inhibit or treat coronavirus infections, particularly SARS-CoV-2. The application was filed on August 18, 2025, with inventor Jan Remmereit listed.

As this is a patent application, it does not impose immediate regulatory obligations. However, it signifies potential future developments in pharmaceutical treatments for coronaviruses. Companies in the pharmaceutical and biotechnology sectors should be aware of this filing as it may impact their research and development strategies or intellectual property landscape.